High dose dexamethasone as first line therapy of multiple myeloma? A case report
Meregalli, M.; Bertola, G.; Grando, D.
Recenti Progressi in Medicina 89(1): 18-20
1998
ISSN/ISBN: 0034-1193 PMID: 9549388 Document Number: 485114
The authors describe a case of multiple myeloma in which a complete remission was obtained by treatment with high dose dexamethasone. This was the only therapy suitable for the patient because of heavy myelosuppression due to disease and to one course of conventional treatment with melphalan and prednisone. Further trials are needed to evaluate the usefulness and safety of this treatment as first line therapy, especially in the elderly, with pancytopenia and bad performance status.
Document emailed within 1 workday
Related Documents
Numbenjapon, T.; Sriswasdi, C.; Mongkonsritragoon, W.; Leelasiri, A.; Prayoonwiwat, W. 2002: Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma Journal of the Medical Association of Thailand 85(11): 1156-1163Voorhees, P.M.; Usmani, S.Z. 2016: The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy Clinical Advances in Hematology and Oncology: H&o 14(9): 719-728
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Kazandjian, D.; Landgren, O. 2019: Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time Clinical Advances in Hematology and Oncology: H&o 17(10): 559-568
Joffe, J.K.; Bell, J.B.; Denham, S.; Adshead, F.; Millar, J.L.; Millar, B.C. 1995: G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM) Experimental Hematology 23(4): 376-382
Mizuno, H.; Ninomiya, N.; Ohta, H.; Tokoro, K.; Yasuma, A.; Ohnishi, K.; Ikeda, Y. 1983: Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(11): 2286-2291
Maeda, M.; Tateishi, H.; Takaiwa, H.; Kinoshita, G.; Hatano, N.; Nakano, K. 1989: High-energy, low-dose radiation therapy for aneurysmal bone cyst. Report of a case Clinical Orthopaedics and Related Research 1989(243): 200-203
Mitsugi, K.; Yasutake, T.; Etoh, T.; Ishimaru, T.; Ueda, A.; Nakano, S.; Niho, Y. 1993: Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2387-2390
Rajkumar, S.V. 2008: Controversies regarding the use of dexamethasone in patients with multiple myeloma Clinical Advances in Hematology and Oncology: H&o 6(2): 103; 141
Dauth, J.; Politzer, W.M.; Christodoulou, A.G.; De Coning, J.P.; Robertson, T.; Du Plessis, D.P. 1985: IgD multiple myeloma. A case report South African Medical Journal 68(13): 965-966
Wölfler, A.; Bauer, F.; Zollner, G.; Weber, K.; Sill, H.; Linkesch, W. 2003: Fatal sepsis after thalidomide/dexamethasone treatment in two patients with multiple myeloma Haematologica 88(4): Elt12
Matsumoto, M.; Yamashita, J.; Okamoto, S.; Handa, H.; Sawada, H.; Abe, M. 1984: High dose ACNU and radiation therapy with autologous bone marrow rescue for a patient with cerebellar medulloblastoma: case report No Shinkei Geka. Neurological Surgery 12(6): 731-736
Zamiatina, V.I.; Magomedova, A.U.; Kravchenko, S.K.; Giliazitdinova, E.A.; Iliushkina, E.A.; Zvonkov, E.E.; Kaplanskaia, I.B.; Obukhova, T.N.; Kliasova, G.A.; Gorgidze, L.A.; Churakova, Z.V.; Kremenetskaia, A.M.; Vorob'ev, A.I. 2009: First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report Terapevticheskii Arkhiv 81(7): 71-75
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30
Nomura, N.; Nagasaki, A.; Ouchi, E. 1978: Myocardial amyloidosis associated with multiple myeloma--a case report Nihon Rinsho. Japanese Journal of Clinical Medicine 36(4): 900-904
Di Bisceglie, A.M.; Hodkinson, H.J. 1982: Multiple myeloma and pernicious anaemia. A case report South African Medical Journal 62(15): 535-536
Marín-López, A.; Landero de Ruiz, N.; Armenta Olvera, T.; Ruiz-Argüelles, G.J. 1982: IgM multiple myeloma. Case report and review of the literature [ Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 34(2): 175-178
Lasso Luis, O.; Jiménez Antolín, J.; García Lozano, C.; Galán Morales, J.; Galdeano Granda, E. 1996: Laryngeal amyloidosis and multiple myeloma: a case report Anales Otorrinolaringologicos Ibero-Americanos 23(5): 511-524
Dadacaridou, M.; Papanicolaou, X.; Maltesas, D.; Megalakaki, C.; Patos, P.; Panteli, K.; Repousis, P.; Mitsouli-Mentzikof, C. 2007: Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 41-44